Nuveen Asset Management LLC reduced its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 19.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 146,580 shares of the company's stock after selling 35,819 shares during the quarter. Nuveen Asset Management LLC owned approximately 0.26% of Molina Healthcare worth $42,662,000 as of its most recent filing with the SEC.
A number of other institutional investors have also bought and sold shares of MOH. Colonial Trust Co SC boosted its stake in Molina Healthcare by 930.0% during the fourth quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after acquiring an additional 93 shares in the last quarter. Wingate Wealth Advisors Inc. bought a new position in shares of Molina Healthcare during the 4th quarter worth approximately $52,000. Hurley Capital LLC bought a new stake in Molina Healthcare during the fourth quarter worth $55,000. EverSource Wealth Advisors LLC raised its stake in shares of Molina Healthcare by 81.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after purchasing an additional 88 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. raised its position in Molina Healthcare by 337.0% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock worth $58,000 after acquiring an additional 155 shares during the period. Institutional investors own 98.50% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on the company. Guggenheim initiated coverage on Molina Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. Wells Fargo & Company upgraded shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $295.00 to $372.00 in a research note on Wednesday, March 5th. UBS Group lowered their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Robert W. Baird restated a "neutral" rating and set a $375.00 price objective (up previously from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Finally, Truist Financial lifted their price target on shares of Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $365.38.
Check Out Our Latest Stock Analysis on MOH
Molina Healthcare Price Performance
MOH opened at $325.14 on Tuesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The stock's 50 day moving average price is $324.27 and its 200-day moving average price is $308.22. The stock has a market capitalization of $17.62 billion, a PE ratio of 15.91, a price-to-earnings-growth ratio of 1.06 and a beta of 0.63. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $365.23.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. The firm had revenue of $11.15 billion for the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The business's revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $5.73 EPS. On average, equities research analysts predict that Molina Healthcare, Inc. will post 24.4 EPS for the current year.
Insiders Place Their Bets
In other news, Director Richard M. Schapiro sold 669 shares of the stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the sale, the director now owns 11,244 shares in the company, valued at $3,603,702. This represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now directly owns 17,375 shares in the company, valued at approximately $5,235,608.75. The trade was a 5.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 89,169 shares of company stock worth $28,520,995. 1.10% of the stock is currently owned by company insiders.
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.